| Serial Number | 88814224 |
| Word Mark | TAKING CANCER PERSONALLY |
| Filing Date | Friday, February 28, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, November 7, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 9, 2021 |
| Goods and Services | Providing online non-downloadable reports to others in the fields of pathology, medical diagnostic testing and oncology testing; education services, namely, providing training and on-demand on-line training in the form of courses, seminars and workshops in the fields of health, health related topics, cancer, cancer pathology, pathology, scientific testing and research services, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; education services, namely, providing non-downloadable webinars in the fields of health, health related topics, cancer, cancer pathology, pathology, scientific testing and research services, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; providing online, non-downloadable reports for others in the fields of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions |
| Goods and Services | Medical tests kits primarily comprised of medical diagnostic reagents and assays for testing body fluids |
| Goods and Services | Printed medical reports in the field of cancer research; printed publications, namely, newsletters and abstracts in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; printed reports for others in the fields of pathology, medical diagnostic testing and oncology testing |
| Goods and Services | Pre-packaged medical tests kits and medical test kits to aid in the diagnosis of disease or cancer, namely, kits primarily composed of DNA probes being biochemical reagents used for detecting and analyzing molecules in protein or nucleotide arrays and also containing clinical medical reagents and antibodies for use in disease testing for clinical medical laboratory use |
| Goods and Services | Medical research; genetic mapping for scientific purposes, namely, gene sequencing; genetic testing and sequencing for scientific purposes; molecular sequencing for scientific purposes; cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, all being for scientific and/or research purposes; clinical study and testing of cells all being for scientific purposes; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells for scientific or research purposes; medical and scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer; providing scientific and/or research information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells all for scientific and/or research purposes; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information in the nature of providing temporary use of nondownloadable cloud based software for providing information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; temporary use of online non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; non-downloadable computer software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing for scientific purposes in the field of human disease and human medical conditions; clinical laboratory research services, oncology reference laboratory services for research or scientific purposes, providing medical research information and interactive information to others in the fields of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing cloud-based information in the nature of providing temporary use of nondownloadable cloud based software for providing information to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online non-downloadable Internet-based software for medical testing and analysis of medical test results; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 5, 2020 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 5, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks. |
| US Class Codes | 002, 005, 022, 023, 029, 037, 038, 050 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 5, 2020 |
| Primary Code | 016 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 5, 2020 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 5, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NeoGenomics Laboratories, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Naples, FL 34103 |
| Party Name | NeoGenomics Laboratories, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Naples, FL 34103 |
| Event Date | Event Description |
| Monday, November 7, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, November 7, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, June 13, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, June 13, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, June 13, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, April 7, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, April 6, 2022 | SOU EXTENSION 2 GRANTED |
| Monday, April 4, 2022 | SOU EXTENSION 2 FILED |
| Monday, April 4, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, October 8, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 7, 2021 | SOU EXTENSION 1 GRANTED |
| Monday, October 4, 2021 | SOU EXTENSION 1 FILED |
| Thursday, October 7, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, October 4, 2021 | SOU TEAS EXTENSION RECEIVED |
| Monday, October 4, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, October 4, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, October 4, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, October 4, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, October 4, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, April 6, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 9, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 9, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 20, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, January 6, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 30, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 30, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 28, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 7, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 7, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, December 7, 2020 | NON-FINAL ACTION WRITTEN |
| Monday, December 7, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, December 7, 2020 | FINAL REFUSAL E-MAILED |
| Monday, December 7, 2020 | FINAL REFUSAL WRITTEN |
| Monday, November 16, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, November 16, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 16, 2020 | ASSIGNED TO LIE |
| Wednesday, October 14, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, October 14, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, October 14, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 14, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, October 14, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, October 14, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, April 26, 2020 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Sunday, April 26, 2020 | PRIORITY ACTION E-MAILED |
| Sunday, April 26, 2020 | PRIORITY ACTION WRITTEN |
| Friday, April 17, 2020 | ASSIGNED TO EXAMINER |
| Thursday, March 5, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 5, 2020 | NEW APPLICATION ENTERED |